日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhibition of AKT enhances chemotherapy efficacy and synergistically interacts with targeting of the Inhibitor of apoptosis proteins in oesophageal adenocarcinoma.

抑制 AKT 可增强化疗疗效,并与靶向食管腺癌中的凋亡抑制蛋白产生协同作用

Stevenson Leanne, Cairns Lauren, Li Xiaodun, Jammula Sriganesh, Taylor Harriet, Douglas Rosalie, McCabe Niamh, Gavory Gerald, Jacq Xavier, Fitzgerald Rebecca C, Kennedy Richard D, Harrison Timothy, Turkington Richard C

Deubiquitylating enzymes and drug discovery: emerging opportunities

去泛素化酶与药物发现:新兴机遇

Harrigan, Jeanine A; Jacq, Xavier; Martin, Niall M; Jackson, Stephen P

A population-based analysis of germline BAP1 mutations in melanoma

基于人群的黑色素瘤中生殖系BAP1突变分析

O'Shea, Sally J; Robles-Espinoza, Carla Daniela; McLellan, Lauren; Harrigan, Jeanine; Jacq, Xavier; Hewinson, James; Iyer, Vivek; Merchant, Will; Elliott, Faye; Harland, Mark; Bishop, D Timothy; Newton-Bishop, Julia A; Adams, David J

Monitoring Target Engagement of Deubiquitylating Enzymes Using Activity Probes: Past, Present, and Future

利用活性探针监测去泛素化酶的靶标结合:过去、现在和未来

Harrigan, Jeanine; Jacq, Xavier

Deubiquitylating enzymes and DNA damage response pathways

去泛素化酶和DNA损伤反应通路

Jacq, Xavier; Kemp, Mark; Martin, Niall M B; Jackson, Stephen P

Functional proteomics mapping of a human signaling pathway.

人类信号通路的功能蛋白质组学图谱

Colland Frédéric, Jacq Xavier, Trouplin Virginie, Mougin Christelle, Groizeleau Caroline, Hamburger Alexandre, Meil Alain, Wojcik Jérôme, Legrain Pierre, Gauthier Jean-Michel